Common Contracts
3 similar Lease Agreement contracts by Biomarin Pharmaceutical Inc, Ligand Pharmaceuticals Inc
LEASE 3911/3931 SVB, LLC, a California limited liability company as Landlord, and LIGAND PHARMACEUTICALS INCORPORATED, a Delaware corporation, as Tenant. 3911 Sorrento Valley Boulevard San Diego, California 92121Lease Agreement • November 10th, 2015 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • California
This LEASE (the “Lease”), dated as of the date set forth in Section 1 of the Summary of Basic Lease Information (the “Summary”), below, is made by and between 3911/3931 SVB, LLC, a California limited liability company (“Landlord”), and LIGAND PHARMACEUTICALS INCORPORATED, a Delaware corporation (“Tenant”).
LEASE SAN RAFAEL CORPORATE CENTER 770 Lindaro Street San Rafael, California SR CORPORATE CENTER PHASE TWO, LLC, a Delaware limited liability company as Landlord, and BIOMARIN PHARMACEUTICAL INC, a Delaware corporation as Tenant.Lease Agreement • February 22nd, 2012 • Biomarin Pharmaceutical Inc • Pharmaceutical preparations • California
This Lease (the “Lease”), dated as of the date set forth in Section 1 of the Summary of Basic Lease Information (the “Summary”), below, is made by and between SR CORPORATE CENTER PHASE TWO, LLC, a Delaware limited liability company (“Landlord”), and BIOMARIN PHARMACEUTICAL INC., a Delaware corporation (“Tenant”).
LEASE SAN RAFAEL CORPORATE CENTER 790 Lindaro Street San Rafael, California SR CORPORATE CENTER PHASE TWO, LLC, a Delaware limited liability company as Landlord, and BIOMARIN PHARMACEUTICAL INC, a Delaware corporation as Tenant.Lease Agreement • February 22nd, 2012 • Biomarin Pharmaceutical Inc • Pharmaceutical preparations • California
This Lease (the “Lease”), dated as of the date set forth in Section 1 of the Summary of Basic Lease Information (the “Summary”), below, is made by and between SR CORPORATE CENTER PHASE TWO, LLC, a Delaware limited liability company (“Landlord”), and BIOMARIN PHARMACEUTICAL INC., a Delaware corporation (“Tenant”).
